Razadyne and Ranexa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Razadyne (galantamine hydrobromide) and Ranexa (ranolazine). Common drug interactions include infusion site haemorrhage among females and hiccups among males.

The phase IV clinical study analyzes what interactions people have when they take Razadyne and Ranexa. It is created by eHealthMe based on reports of 9 people who take the same drugs from the FDA, and is updated regularly.

What is Razadyne?

Razadyne has active ingredients of galantamine hydrobromide. It is often used in insomnia. eHealthMe is studying from 691 Razadyne users. Check the latest studies of Razadyne.

What is Ranexa?

Ranexa has active ingredients of ranolazine. It is often used in angina. eHealthMe is studying from 11,758 Ranexa users. Check the latest studies of Ranexa.



On Jul, 12, 2026

9 people who take Razadyne and Ranexa together, and have interactions are studied.

Razadyne and Ranexa drug interactions.

What are the common drug interactions of Razadyne and Ranexa, by gender? *:

female:

  1. Infusion site haemorrhage (bleeding from infusion site)
  2. Infusion site pain
  3. Infusion site swelling
  4. Contusion (a type of hematoma of tissue in which capillaries)

male:

  1. Hiccups (an involuntary spasm of the diaphragm and respiratory organs, with a sudden closure of the glottis and a sound like a cough)
  2. Oropharyngeal pain
  3. Tremor (trembling or shaking movements in one or more parts of your body)
  4. Cardiac failure congestive
  5. Chronic kidney disease
  6. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  7. Non-cardiac chest pain
  8. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  9. Renal failure (kidney dysfunction)

What are the common drug interactions of Razadyne and Ranexa, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Chronic kidney disease

60+:

  1. Hiccups (an involuntary spasm of the diaphragm and respiratory organs, with a sudden closure of the glottis and a sound like a cough)
  2. Oropharyngeal pain
  3. Infusion site pain
  4. Infusion site swelling
  5. Renal failure (kidney dysfunction)
  6. Tremor (trembling or shaking movements in one or more parts of your body)
  7. Cardiac failure congestive
  8. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  9. Non-cardiac chest pain
  10. Chronic kidney disease

* Approximation only. Some reports may have incomplete information.

Do you take Razadyne and Ranexa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Razadyne and Ranexa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Razadyne:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ranexa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Razadyne and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ranexa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on galantamine hydrobromide and ranolazine (the active ingredients of Razadyne and Ranexa, respectively), and Razadyne and Ranexa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: